157 related articles for article (PubMed ID: 12586295)
1. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.
Wong N; Chan A; Lee SW; Lam E; To KF; Lai PB; Li XN; Liew CT; Johnson PJ
J Hepatol; 2003 Mar; 38(3):298-306. PubMed ID: 12586295
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
Ma NF; Hu L; Fung JM; Xie D; Zheng BJ; Chen L; Tang DJ; Fu L; Wu Z; Chen M; Fang Y; Guan XY
Hepatology; 2008 Feb; 47(2):503-10. PubMed ID: 18023026
[TBL] [Abstract][Full Text] [Related]
3. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
[TBL] [Abstract][Full Text] [Related]
4. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance].
Li JT; Liu W; Kuang ZH; Chen HK; Li DJ; Feng QS; Liu QC; Hu B
Ai Zheng; 2003 Jul; 22(7):695-9. PubMed ID: 12866958
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.
Forus A; Berner JM; Meza-Zepeda LA; Saeter G; Mischke D; Fodstad O; Myklebost O
Br J Cancer; 1998 Aug; 78(4):495-503. PubMed ID: 9716033
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.
Chen L; Chan TH; Guan XY
Acta Pharmacol Sin; 2010 Sep; 31(9):1165-71. PubMed ID: 20676120
[TBL] [Abstract][Full Text] [Related]
7. CD1d gene is a target for a novel amplicon at 1q22-23.1 in human hepatocellular carcinoma.
Zhang SG; Song WQ; Gao YT; Yang B; Du Z
Mol Biol Rep; 2010 Jan; 37(1):381-7. PubMed ID: 19757161
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas.
Forus A; Weghuis DO; Smeets D; Fodstad O; Myklebost O; van Kessel AG
Genes Chromosomes Cancer; 1995 Sep; 14(1):8-14. PubMed ID: 8527390
[TBL] [Abstract][Full Text] [Related]
10. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
[TBL] [Abstract][Full Text] [Related]
11. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
Guan XY; Fang Y; Sham JS; Kwong DL; Zhang Y; Liang Q; Li H; Zhou H; Trent JM
Genes Chromosomes Cancer; 2000 Oct; 29(2):110-6. PubMed ID: 10959090
[TBL] [Abstract][Full Text] [Related]
12. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma.
Sy SM; Wong N; Lai PB; To KF; Johnson PJ
Mod Pathol; 2005 May; 18(5):686-92. PubMed ID: 15605078
[TBL] [Abstract][Full Text] [Related]
13. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization.
Hamon-Benais C; Ingster O; Terris B; Couturier-Turpin MH; Bernheim A; Feldmann G
Hepatology; 1996 Mar; 23(3):429-35. PubMed ID: 8617421
[TBL] [Abstract][Full Text] [Related]
14. Infrequent amplification of JUN in hepatocellular carcinoma.
Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
[TBL] [Abstract][Full Text] [Related]
15. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
16. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization.
Zimonjic DB; Keck CL; Thorgeirsson SS; Popescu NC
Hepatology; 1999 Apr; 29(4):1208-14. PubMed ID: 10094966
[TBL] [Abstract][Full Text] [Related]
17. Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21.
Meza-Zepeda LA; Forus A; Lygren B; Dahlberg AB; Godager LH; South AP; Marenholz I; Lioumi M; Flørenes VA; Maelandsmo GM; Serra M; Mischke D; Nizetic D; Ragoussis J; Tarkkanen M; Nesland JM; Knuutila S; Myklebost O
Oncogene; 2002 Mar; 21(14):2261-9. PubMed ID: 11948409
[TBL] [Abstract][Full Text] [Related]
18. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.
Qin LX; Tang ZY; Sham JS; Ma ZC; Ye SL; Zhou XD; Wu ZQ; Trent JM; Guan XY
Cancer Res; 1999 Nov; 59(22):5662-5. PubMed ID: 10582679
[TBL] [Abstract][Full Text] [Related]
19. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
[TBL] [Abstract][Full Text] [Related]
20. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma.
Midorikawa Y; Tsutsumi S; Nishimura K; Kamimura N; Kano M; Sakamoto H; Makuuchi M; Aburatani H
Cancer Res; 2004 Oct; 64(20):7263-70. PubMed ID: 15492245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
